phenytoin has been researched along with n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Aktas, CC; Piskin, AK; Zeybek, ND | 1 |
2 other study(ies) available for phenytoin and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
In vitro effects of phenytoin and DAPT on MDA-MB-231 breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dipeptides; Drug Interactions; Female; Humans; In Vitro Techniques; Matrix Metalloproteinase 9; NAV1.5 Voltage-Gated Sodium Channel; Phenytoin; Proto-Oncogene Proteins; Receptor, Notch4; Receptors, Notch; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1 | 2015 |